Person attributes
Dr. Stephen Elledge is a world-renowned leader in the field of the genetics, biochemistry, genomics, and proteomics of cancer cell biology. He is currently the Gregor Mendel Professor of Genetics and Medicine at Harvard Medical School and Brigham and Women’s Hospital, and is an investigator with the Howard Hughes Medical Institute. Steve has published more than 250 articles that include groundbreaking contributions to the study of proteins and biochemical pathways that regulate the cell division cycle, how cells sense and respond to DNA damage, how cells selectively destroy proteins in response to signals and how these pathways are usurped in human cancer.
Steve has received numerous awards for his research, including the 2017 Breakthrough Prize in Life Sciences, 2015 Albert Lasker Basic Medical Research Award, the Gairdner International Award, the Gruber Prize in Genetics, the National Academy of Sciences Award in Molecular Biology, the Genetics Society of America Medal and the Paul Marks Prize for Cancer Research, among others. He is a member of National Academy of Sciences, the American Academy of Arts and Sciences and Institute of Medicine of the National Academies.
Steve holds a Ph.D. in biology from the Massachusetts Institute of Technology, a B.S. in chemistry from the University of Illinois and completed his postdoctoral studies at Stanford University.
